The acyclic nucleoside phosphonates from inception to clinical use: Historical perspective
Prophylactic treatment with recombinant Eimeria protein, alone or in combination with an agonist cocktail, protects mice from Banzi virus infection
Inhibition of multiple strains of Venezuelan equine encephalitis virus by a pool of four short interfering RNAs
The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1
Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus
CD81 down-regulation on B cells is associated with the response to interferon-alpha-based treatment for chronic hepatitis C virus infection
In vitro evaluation of the anti-orf virus activity of alkoxyalkyl esters of CDV, cCDV and ( S) -HPMPA
Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide
SEQHEPB: A sequence analysis program and relational database system for chronic hepatitis B
Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan
Herpes glycoprotein gL is distantly related to chemokine receptor ligands
Synthesis and antiviral evaluation of alkoxyalkyl-phosphate conjugates of cidofovir and adefovir
Corrigendum to “Inhibition of hepatitis B virus by D-fraction from Grifola frondosa: Synergistic effect of combination with interferon-α in HepG2 2.2.15” [Antiviral Res. 72 (2006) 162–165],